Edward Wolin, MD

Edward M. Wolin, MD, an internationally-renowned authority on neuroendocrine tumors, is Director of the Center for Carcinoid and Neuroendocrine Tumors and Professor of Medicine, Hematology and Medical Oncology. He is the second director of the Center, which was founded by Richard P. Warner, MD, Professor of Medicine, Gastroenterology.

The multi-disciplinary center features a robust research program with clinical trials aimed at finding the most effective treatments, including immunotherapy, biologic agents, targeted radiation therapy, and new approaches in molecular imaging for diagnosis. Dr. Wolin has pioneered innovative therapies with novel somatostatin analogs, mTOR inhibitors, anti-angiogenic drugs, and peptide receptor radiotherapy.

Prior to joining Mount Sinai, Dr. Wolin was Director of the Neuroendocrine Tumor Program at Montefiore Einstein Center for Cancer Care. Previously, he worked for more than two decades with Cedars-Sinai Medical Center in Los Angeles, where he founded and directed one of the largest carcinoid and neuroendocrine tumor programs in the country. Currently, Dr. Wolin serves as Co-Medical Director for the Carcinoid Cancer Foundation and is on the Carcinoid Cancer Research Grants Scientific Review Committee for the American Association for Cancer Research. He is a reviewer for numerous journals, including Journal of Clinical Oncology, Molecular Cancer Therapeutics, Clinical Cancer Research, and The Lancet Oncology.